|By Marketwired .||
|April 7, 2014 02:00 AM EDT||
MANCHESTER, UNITED KINGDOM -- (Marketwired) -- 04/07/14 -- Epistem Holdings Plc (LSE:EHP), Manchester, UK, the biotechnology and personalized medicine company, today announced the successful installation of the Bruker Xtreme Imaging System within its contract research services division. This is the first such machine in the UK and will enable Epistem to expand both the range and throughput of its imaging services, particularly in the field of oncology. The Bruker Xtreme provides high sensitivity luminescence, fluorescence, radio-isotopic and radiographic (X-ray) imaging. Combined with Epistem's specialized pre-clinical knowledge this increases the range of assays the company can provide to its clients as well as their ability to identify new targets for cancer therapy.
"We are excited to have installed the UKs first machine. This new platform combines highly sensitive capabilities in a unified system, and provides us with a means to track tumour cells, visualise inflammation, and provide high throughput pharmacodynamic studies." said Dr. Catherine Booth, Co-Founder and Managing Director of the Contract Services Business. "Epistem's contract research service is committed to providing high quality, reliable and innovative pre-clinical models and services."
Bruker commented "The successful installation of the Xtreme system at Epistem marks our first UK site. The Xtreme is a highly sensitive imaging system with the added advantages of modularity and flexibility. It's unique design will provide major benefits to Epistem's pre-clinical drug development services."
Notes for editors
Epistem is a biotechnology and personalised medicine company commercialising its expertise in stem cells in the areas of epithelial (oncology, gastrointestinal and dermatological) and infectious diseases. Epistem develops innovative therapeutics, biomarkers and diagnostics (Genedrive®) alongside contract research services for drug development companies. The Group's core expertise is focused around the regulation of adult stem cells located in epithelial tissue including the gastrointestinal tract, skin, hair follicles, breast and prostate and utilizing novel, proprietary next generation molecular biology for use in personalised medicine. www.epistem.co.uk
Chief Executive Officer
+44 161 606 7258
Sep. 3, 2015 12:15 PM EDT
Sep. 3, 2015 12:00 PM EDT Reads: 116
In his session at @ThingsExpo, Lee Williams, a producer of the first smartphones and tablets, will talk about how he is now applying his experience in mobile technology to the design and development of the next generation of Environmental and Sustainability Services at ETwater. He will explain how M2M controllers work through wirelessly connected remote controls; and specifically delve into a retrofit option that reverse-engineers control codes of existing conventional controller systems so the...
Sep. 3, 2015 12:00 PM EDT Reads: 244
WebRTC services have already permeated corporate communications in the form of videoconferencing solutions. However, WebRTC has the potential of going beyond and catalyzing a new class of services providing more than calls with capabilities such as mass-scale real-time media broadcasting, enriched and augmented video, person-to-machine and machine-to-machine communications. In his session at @ThingsExpo, Luis Lopez, CEO of Kurento, will introduce the technologies required for implementing thes...
Sep. 3, 2015 11:30 AM EDT
Sep. 3, 2015 11:30 AM EDT
Sep. 3, 2015 11:00 AM EDT Reads: 130
Sep. 3, 2015 10:45 AM EDT Reads: 569
Sep. 3, 2015 10:45 AM EDT
Sep. 3, 2015 10:15 AM EDT Reads: 114
Sep. 3, 2015 10:00 AM EDT Reads: 277
Sep. 3, 2015 10:00 AM EDT Reads: 1,596
Sep. 3, 2015 10:00 AM EDT Reads: 448
Sep. 3, 2015 09:30 AM EDT Reads: 280
While many app developers are comfortable building apps for the smartphone, there is a whole new world out there. In his session at @ThingsExpo, Narayan Sainaney, Co-founder and CTO of Mojio, will discuss how the business case for connected car apps is growing and, with open platform companies having already done the heavy lifting, there really is no barrier to entry.
Sep. 3, 2015 09:30 AM EDT Reads: 207
As more intelligent IoT applications shift into gear, they’re merging into the ever-increasing traffic flow of the Internet. It won’t be long before we experience bottlenecks, as IoT traffic peaks during rush hours. Organizations that are unprepared will find themselves by the side of the road unable to cross back into the fast lane. As billions of new devices begin to communicate and exchange data – will your infrastructure be scalable enough to handle this new interconnected world?
Sep. 3, 2015 09:30 AM EDT Reads: 200